Incidental Pulmonary Nodule Detected on Cardiac CT
A 63-year-old former smoker (30 pack-years, quit 12 years ago) undergoes a coronary calcium score CT. The study incidentally reveals a 9 mm solid pulmonary nodule in the right lower lobe. The patient has no symptoms and no prior chest imaging for comparison. The ordering cardiologist is focused on the calcium score and did not comment on the nodule. The radiologist must decide on the appropriate recommendation and communication.
1. What follow-up is appropriate for a 9 mm solid incidental pulmonary nodule in this patient?
Read the worked answer
Per Fleischner Society guidance for a solid nodule ≥8 mm in a patient with a smoking history, the appropriate follow-up is PET/CT or a dedicated chest CT at 3 months, depending on pretest probability and nodule morphology. Because this patient has a significant smoking history, the nodule is not low-risk, so short-interval CT or PET/CT is appropriate rather than 6–12 month follow-up. The reasoning requires integrating nodule size, patient risk factors, and the fact that no prior imaging exists to establish stability. A calcium score study is not a dedicated chest CT, so the nodule should be re-evaluated with a dedicated protocol.
2. How should the radiologist communicate this finding, given that the ordering physician was focused on the calcium score?
Read the worked answer
The radiologist should directly communicate the incidental pulmonary nodule to the ordering cardiologist and document the communication, because the finding is potentially significant and may not be addressed by the ordering physician's focus. The report should include a clear recommendation for follow-up imaging. This reflects the noninterpretive skill of closed-loop communication for actionable incidental findings, ensuring the finding is not lost in a report focused on coronary calcium.
3. What if the patient had no smoking history and the nodule were 5 mm solid?
Read the worked answer
For a 5 mm solid nodule in a patient with no smoking history and no other risk factors, Fleischner guidance suggests no routine follow-up for a low-risk patient (or follow-up at 6–12 months depending on morphology and risk). The reasoning is that follow-up intensity should scale with nodule size and patient risk; applying the same aggressive algorithm to a low-risk patient with a tiny nodule would generate unnecessary testing and anxiety. The radiologist should document the risk assessment that supports the recommendation.